{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:51:15Z","timestamp":1788580275300,"version":"build-2803163510"},"reference-count":31,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":808,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1111\/ane.12162","type":"journal-article","created":{"date-parts":[[2013,6,15]],"date-time":"2013-06-15T12:21:35Z","timestamp":1371298895000},"page":"422-428","source":"Crossref","is-referenced-by-count":19,"title":["Safety and tolerability of zonisamide in elderly patients with epilepsy"],"prefix":"10.1155","volume":"128","author":[{"given":"E.","family":"Trinka","sequence":"first","affiliation":[{"name":"Department of Neurology; Christian Doppler Klinik; Paracelsus Medical University; Salzburg Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Giorgi","sequence":"additional","affiliation":[{"name":"Eisai Ltd; Hatfield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Patten","sequence":"additional","affiliation":[{"name":"Eisai Ltd; Hatfield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Segieth","sequence":"additional","affiliation":[{"name":"Eisai Ltd; Hatfield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2013,6,15]]},"reference":[{"key":"10.1111\/ane.12162-BIB0001|ane12162-cit-0001","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0140-6736(00)02149-8","article-title":"Epilepsy in elderly people","volume":"355","author":"Stephen","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/ane.12162-BIB0002|ane12162-cit-0002","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1468-1331.2004.00992.x","article-title":"The epidemiology of epilepsy in Europe - a systematic review","volume":"12","author":"Forsgren","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1111\/ane.12162-BIB0003|ane12162-cit-0003","unstructured":"Epilepsy Foundation. Living With Epilepsy - Seniors 2011 http:\/\/www.epilepsyfoundation.org\/livingwithepilepsy\/seniors\/index.cfm"},{"key":"10.1111\/ane.12162-BIB0004|ane12162-cit-0004","unstructured":"Administration on Aging. A Profile of Older Americans 2010 http:\/\/www.aoa.gov\/AoARoot\/Aging_Statistics\/Profile\/2010\/4.aspx"},{"key":"10.1111\/ane.12162-BIB0005|ane12162-cit-0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1034\/j.1600-0404.108.s180.5.x","article-title":"Epilepsy: comorbidity in the elderly","volume":"180","author":"Trinka","year":"2003","journal-title":"Acta Neurol Scand Suppl"},{"issue":"Suppl 2","key":"10.1111\/ane.12162-BIB0006|ane12162-cit-0006","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1212\/WNL.62.5_suppl_2.S24","article-title":"Special considerations in treating the elderly patient with epilepsy","volume":"62","author":"Ramsay","year":"2004","journal-title":"Neurology"},{"key":"10.1111\/ane.12162-BIB0007|ane12162-cit-0007","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S1474-4422(09)70240-6","article-title":"Epilepsy in later life","volume":"8","author":"Brodie","year":"2009","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"10.1111\/ane.12162-BIB0008|ane12162-cit-0008","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.eplepsyres.2005.07.019","article-title":"Outcomes research: clinical trials in the elderly","volume":"68","author":"Leppik","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12162-BIB0009|ane12162-cit-0009","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0920-1211(99)00039-X","article-title":"Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group","volume":"37","author":"Brodie","year":"1999","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12162-BIB0010|ane12162-cit-0010","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/01.WNL.0000167384.68207.3E","article-title":"New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine","volume":"64","author":"Rowan","year":"2005","journal-title":"Neurology"},{"key":"10.1111\/ane.12162-BIB0011|ane12162-cit-0011","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1528-1167.2007.01128.x","article-title":"An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly","volume":"48","author":"Saetre","year":"2007","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12162-BIB0012|ane12162-cit-0012","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2165\/00002512-200118080-00006","article-title":"The tolerability of lamotrigine in elderly patients with epilepsy","volume":"18","author":"Giorgi","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1111\/ane.12162-BIB0013|ane12162-cit-0013","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1525-5050(03)00037-4","article-title":"Safety and tolerability of oxcarbazepine in elderly patients with epilepsy","volume":"4","author":"Kutluay","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12162-BIB0014|ane12162-cit-0014","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.seizure.2010.12.015","article-title":"The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: a one-year observational study","volume":"20","author":"Werhahn","year":"2011","journal-title":"Seizure"},{"key":"10.1111\/ane.12162-BIB0015|ane12162-cit-0015","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/wnf.0b013e3180413d7d","article-title":"Clinical pharmacology and mechanism of action of zonisamide","volume":"30","author":"Biton","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/ane.12162-BIB0016|ane12162-cit-0016","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ane.12016","article-title":"Zonisamide: its pharmacology, efficacy and safety in clinical trials","volume":"194","author":"Brodie","year":"2012","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1111\/ane.12162-BIB0017|ane12162-cit-0017","unstructured":"Zonegran \u00ae Summary of Product Characteristics 2012 http:\/\/www.medicines.org.uk\/emc\/medicine\/16240\/SPC\/Zonegran%20capsules"},{"key":"10.1111\/ane.12162-BIB0018|ane12162-cit-0018","unstructured":"Zonegran\u00ae Prescribing Information 2012 http:\/\/us.eisai.com\/package_inserts\/Zonegran_PI.pdf"},{"key":"10.1111\/ane.12162-BIB0019|ane12162-cit-0019","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1474-4422(12)70105-9","article-title":"Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial","volume":"11","author":"Baulac","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.12162-BIB0020|ane12162-cit-0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.0013-9580.2005.14704.x","article-title":"Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures","volume":"46","author":"Brodie","year":"2005","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12162-BIB0021|ane12162-cit-0021","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1212\/WNL.57.10.1774","article-title":"Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures","volume":"57","author":"Faught","year":"2001","journal-title":"Neurology"},{"key":"10.1111\/ane.12162-BIB0022|ane12162-cit-0022","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.0013-9580.2004.11403.x","article-title":"Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures","volume":"45","author":"Sackellares","year":"2004","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12162-BIB0023|ane12162-cit-0023","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0920-1211(93)90011-U","article-title":"Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial","volume":"15","author":"Schmidt","year":"1993","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12162-BIB0024|ane12162-cit-0024","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.sder.2011.04.002","article-title":"Pruritus in elderly patients-eruptions of senescence","volume":"30","author":"Berger","year":"2011","journal-title":"Semin Cutan Med Surg"},{"issue":"Suppl 8","key":"10.1111\/ane.12162-BIB0025|ane12162-cit-0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/sonc.2002.33534","article-title":"Age, anemia, and fatigue","volume":"29","author":"Aapro","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1111\/ane.12162-BIB0026|ane12162-cit-0026","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/MJT.0b013e3181afbf9f","article-title":"Managing peripheral edema in patients with arterial hypertension","volume":"16","author":"Epstein","year":"2009","journal-title":"Am J Ther"},{"key":"10.1111\/ane.12162-BIB0027|ane12162-cit-0027","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11934-001-0073-1","article-title":"Urinary tract infections in the elderly","volume":"2","author":"Matsumoto","year":"2001","journal-title":"Curr Urol Rep"},{"key":"10.1111\/ane.12162-BIB0028|ane12162-cit-0028","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-230X-8-5","article-title":"Epidemiology of constipation in Europe and Oceania: a systematic review","volume":"8","author":"Peppas","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"10.1111\/ane.12162-BIB0029|ane12162-cit-0029","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.51.5.1256","article-title":"Is the underlying cause of epilepsy a major prognostic factor for recurrence?","volume":"51","author":"Semah","year":"1998","journal-title":"Neurology"},{"key":"10.1111\/ane.12162-BIB0030|ane12162-cit-0030","first-page":"873","volume-title":"Antiepileptic drugs","author":"Shah","year":"2002","edition":"5"},{"key":"10.1111\/ane.12162-BIB0031|ane12162-cit-0031","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/14656560903468728","article-title":"Zonisamide in the treatment of epilepsy","volume":"11","author":"Schulze-Bonhage","year":"2010","journal-title":"Expert Opin Pharmacother"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12162","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12162\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:46:50Z","timestamp":1671540410000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,15]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.12162","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6,15]]}}}